Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BJSE:920925'
s EV-to-FCF Range Over the Past 10 Years
Min: -198.86 Med: -8.09 Max: 1864.03
Current: 375.69
During the past 10 years, the highest EV-to-FCF of Huizhou Jinghao Medical Technology Co was 1864.03. The lowest was -198.86. And the median was -8.09.
BJSE:920925's EV-to-FCF is ranked worse than 96.58% of 409
companies
in the Medical Devices & Instruments industry
Industry Median: 24.17
vs BJSE:920925: 375.69
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Huizhou Jinghao Medical Technology Co (BJSE:920925) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Huizhou Jinghao Medical Technology Co's PE Ratio (TTM) for today is calculated as:
Huizhou Jinghao Medical Technology Co's share price for today is ¥12.13.
Huizhou Jinghao Medical Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.017.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Huizhou Jinghao Medical Technology Co EV-to-FCF Related Terms
Huizhou Jinghao Medical Technology Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huizhou Jinghao Medical Technology Co EV-to-FCF Chart
BJSE:920925 vs ABT, SYK, MDT: EV-to-FCF Comparison
For the Medical Devices subindustry, Huizhou Jinghao Medical Technology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Huizhou Jinghao Medical Technology Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Huizhou Jinghao Medical Technology Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Huizhou Jinghao Medical Technology Co's EV-to-FCF falls into.
Huizhou Jinghao Medical Technology Co's current Enterprise Value is ¥1,091.0 Mil.
Huizhou Jinghao Medical Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Huizhou Jinghao Medical Technology Co (BJSE:920925) has a EV-to-FCF of 375.69 as of Sep. 06, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Huizhou Jinghao Medical Technology Co and its competitors. According to the industry distribution chart, Huizhou Jinghao Medical Technology Co ranks #395 out of 409 companies in the Medical Devices & Instruments industry, placing it in the top 96.6%.
Is Huizhou Jinghao Medical Technology Co's EV-to-FCF too high?
Huizhou Jinghao Medical Technology Co's current EV-to-FCF is 375.69. The Medical Devices & Instruments industry median EV-to-FCF is 24.17. Huizhou Jinghao Medical Technology Co's value of 375.69 is 1454.4% above this industry median. Based on the distribution chart, Huizhou Jinghao Medical Technology Co ranks #395 out of 409 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Huizhou Jinghao Medical Technology Co has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Huizhou Jinghao Medical Technology Co's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Huizhou Jinghao Medical Technology Co ranks #395 out of 409 companies for EV-to-FCF. This places Huizhou Jinghao Medical Technology Co in the lower half of its industry. The industry median EV-to-FCF is 24.17. Huizhou Jinghao Medical Technology Co's value of 375.69 is 1454.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 24.17, based on 409 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Huizhou Jinghao Medical Technology Co's current EV-to-FCF of 375.69 is 1454.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Huizhou Jinghao Medical Technology Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 24.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Huizhou Jinghao Medical Technology Co's current EV-to-FCF is 375.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Huizhou Jinghao Medical Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Huizhou Jinghao Medical Technology Co (BJSE:920925) is currently considered Possible Value Trap. The stock's GF Value™ is ¥18.93, compared to a current price of ¥12.13 — trading 35.9% below its estimated fair value. The current EV-to-FCF is 375.69 and 1454.4% above the Medical Devices & Instruments industry median of 24.17. Huizhou Jinghao Medical Technology Co's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Huizhou Jinghao Medical Technology Co (BJSE:920925), the current EV-to-FCF is 375.69 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Huizhou Jinghao Medical Technology Co (BJSE:920925) Overvalued in 2026?
Based on GuruFocus' analysis, Huizhou Jinghao Medical Technology Co stock appears to be undervalued.
The current stock price of ¥12.13 is trading 35.9% below its estimated GF Value™ of ¥18.93.
GuruFocus considers Huizhou Jinghao Medical Technology Co to be Possible Value Trap.
Key valuation signals for BJSE:920925:
EV-to-FCF: 375.69
GF Value™: ¥18.93 vs. price of ¥12.13 (35.9% below fair value)
Industry Position: 1454.4% above the Medical Devices & Instruments median (#395 of 409)
No single metric tells the full story. See the BJSE:920925 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920925 has been successfully added to your 
